Folgen
Hongxia Lin
Hongxia Lin
Rutgers University, Cancer Institute of New Jersey
Keine bestätigte E-Mail-Adresse
Titel
Zitiert von
Zitiert von
Jahr
Targeting tumor metabolism with 2‐deoxyglucose in patients with castrate‐resistant prostate cancer and advanced malignancies
M Stein, H Lin, C Jeyamohan, D Dvorzhinski, M Gounder, K Bray, S Eddy, ...
The Prostate 70 (13), 1388-1394, 2010
2972010
Contribution of serine, folate and glycine metabolism to the ATP, NADPH and purine requirements of cancer cells
PM Tedeschi, EK Markert, M Gounder, H Lin, D Dvorzhinski, SC Dolfi, ...
Cell death & disease 4 (10), e877-e877, 2013
2762013
Air-liquid interface (ALI) culture of human bronchial epithelial cell monolayers as an in vitro model for airway drug transport studies
H Lin, H Li, HJ Cho, S Bian, HJ Roh, MK Lee, JS Kim, SJ Chung, CK Shim, ...
Journal of pharmaceutical sciences 96 (2), 341-350, 2007
1942007
Liposome formulation of paclitaxel with enhanced solubility and stability
T Yang, FD Cui, MK Choi, H Lin, SJ Chung, CK Shim, DD Kim
Drug delivery 14 (5), 301-308, 2007
1562007
Enhancing effect of surfactants on fexofenadineĚHCl transport across the human nasal epithelial cell monolayer
H Lin, M Gebhardt, S Bian, KA Kwon, CK Shim, SJ Chung, DD Kim
International journal of pharmaceutics 330 (1-2), 23-31, 2007
1102007
Air-Liquid Interface Culture of Serially Passaged Human Nasal Epithelial Cell Monolayer for In Vitro Drug Transport Studies
MK Lee, JW Yoo, H Lin, YS Kim, DD Kim, YM Choi, SK Park, CH Lee, ...
Drug Delivery 12 (5), 305-311, 2005
832005
Neutrophils clear bacteria associated with parasitic nematodes augmenting the development of an effective Th2-type response
JT Pesce, Z Liu, H Hamed, F Alem, J Whitmire, H Lin, Q Liu, JF Urban, ...
The Journal of Immunology 180 (1), 464-474, 2008
562008
Transport of anti-allergic drugs across the passage cultured human nasal epithelial cell monolayer
H Lin, JW Yoo, HJ Roh, MK Lee, SJ Chung, CK Shim, DD Kim
European journal of pharmaceutical sciences 26 (2), 203-210, 2005
552005
A phase II trial of riluzole, an antagonist of metabotropic glutamate receptor 1 (GRM 1) signaling, in patients with advanced melanoma
JM Mehnert, AW Silk, JH Lee, L Dudek, BS Jeong, J Li, JM Schenkel, ...
Pigment cell & melanoma research 31 (4), 534-540, 2018
472018
Zinc metallochaperones reactivate mutant p53 using an ON/OFF switch mechanism: a new paradigm in cancer therapeutics
X Yu, S Kogan, Y Chen, AT Tsang, T Withers, H Lin, J Gilleran, B Buckley, ...
Clinical cancer research 24 (18), 4505-4517, 2018
342018
Suppression of cytosolic NADPH pool by thionicotinamide increases oxidative stress and synergizes with chemotherapy
PM Tedeschi, HX Lin, M Gounder, JE Kerrigan, EE Abali, K Scotto, ...
Molecular pharmacology 88 (4), 720-727, 2015
292015
A phase I trial of MK-2206 and hydroxychloroquine in patients with advanced solid tumors
JM Mehnert, AD Kaveney, J Malhotra, K Spencer, D Portal, S Goodin, ...
Cancer chemotherapy and pharmacology 84, 899-907, 2019
262019
Quantification of folate metabolism using transient metabolic flux analysis
PM Tedeschi, N Johnson-Farley, H Lin, LM Shelton, T Ooga, G Mackay, ...
Cancer & metabolism 3, 1-14, 2015
232015
A phase I study of AT-101, a BH3 mimetic, in combination with paclitaxel and carboplatin in solid tumors
MN Stein, S Goodin, M Gounder, D Gibbon, R Moss, D Portal, D Lindquist, ...
Investigational new drugs 38, 855-865, 2020
222020
Expression and functional activity of P-glycoprotein in passaged primary human nasal epithelial cell monolayers cultured by the air–liquid interface method for nasal drug …
HJ Cho, MK Choi, H Lin, JS Kim, SJ Chung, CK Shim, DD Kim
Journal of Pharmacy and Pharmacology 63 (3), 385-391, 2011
182011
Preliminary results of a phase I trial of ABT-888, a poly (ADP-ribose) polymerase (PARP) inhibitor, in combination with cyclophosphamide.
AR Tan, D Gibbon, MN Stein, RA Moss, V Karantza, H Lin, M Gounder, ...
Journal of Clinical Oncology 28 (15_suppl), 3000-3000, 2010
182010
A validated HPLC assay for the determination of R-(−)-gossypol in human plasma and its application in clinical pharmacokinetic studies
H Lin, MK Gounder, JR Bertino, ANT Kong, RS DiPaola, MN Stein
Journal of pharmaceutical and biomedical analysis 66, 371-375, 2012
162012
Pharmacokinetics and pharmacodynamics of 3, 3′-diindolylmethane (DIM) in regulating gene expression of phase II drug metabolizing enzymes
TY Wu, Y Huang, C Zhang, ZY Su, S Boyanapalli, TO Khor, H Wang, H Lin, ...
Journal of pharmacokinetics and pharmacodynamics 42, 401-408, 2015
152015
A second target of benzamide riboside: Dihydrofolate reductase
B Roussel, N Johnson-Farley, JE Kerrigan, KW Scotto, D Banerjee, ...
Cancer biology & therapy 13 (13), 1290-1298, 2012
142012
Cefoxitin plasma and subcutaneous adipose tissue concentration in patients undergoing sleeve gastrectomy
L Brunetti, L Kagan, G Forrester, LM Aleksunes, H Lin, S Buyske, ...
Clinical therapeutics 38 (1), 204-210, 2016
122016
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20